CARLOS CHACCOUR

Carlos Chaccour is a researcher specializing in global health, particularly focused on malaria control and drug repurposing. His work integrates clinical trials, field epidemiology, and innovative technologies like AI-driven cough monitoring systems. He collaborates on large-scale studies such as BOHEMIA, investigating ivermectin's role in malaria vector control and collateral health benefits. His research spans tropical disease epidemiology, environmental health, and public health policy, emphasizing One Health approaches to combat neglected tropical diseases.

Key research areas include:

• Evaluation of ivermectin's efficacy and safety in malaria and other parasitic infections
• Development of digital health tools for respiratory disease surveillance
• Impact assessment of air pollution on respiratory illnesses
• Health equity in malaria-endemic regions, especially in Mozambique and Venezuela

His studies frequently employ randomized controlled trials, cohort designs, and advanced analytical techniques like MALDI-TOF MS for biomarker discovery. He advocates for evidence-based policy changes to address gaps in global health interventions, particularly in resource-limited settings.